4 matches for your search in the start-up spotlight
rssGroundbreaking patented molecular diagnostic kit poised to provide game-changing autonomous Lyme detection in minutes
27-May-2024
En Carta Diagnostics, a deeptech start-up developing rapid Point-of-Care (POC) molecular diagnostics kits, announces €1.5M ($1.63M) in pre-seed funding. This investment will enable En Carta to make a substantial leap forward in achieving preclinical data on a prototype diagnostic kit for its ...
Spartha Medical receives €2.4M in financing from European Innovation Council
01-Feb-2022
Spartha Medical, a French medtech start-up specialized in developing multifunctional antimicrobial, antiviral and anti-inflammatory coatings, announces it has received €2.4M ($2.75M) in grants and an additional undisclosed equity financing from the European Innovation Council (EIC) Fund. Spartha ...
The Belgian start-up is developing an effective and reproducible phage therapy approach that offers a personalized solution to the major issue of AntiMicrobial Resistance
13-Dec-2021
Vésale Bioscience, a biotech company specializing in phage therapy, with a particular focus on research into alternative solutions to antibiotics and the development of treatments for multidrug-resistant infections, announced that it has been awarded the prize for most innovative start-up in life ...
Exciva raises €9 million in Series A round
02-Nov-2021
Exciva GmbH, a clinical biotech startup developing a novel therapeutic compound for treating agitation/aggression in Alzheimer’s disease, announces the closing of a Series A financing of €9 million ($10M) led by Andera Partners. LBBW Venture Capital and Cure8 also participated in the round. This ...